JNNP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

Published Online First: 21 November 2006. doi:10.1136/jnnp.2006.091116
Journal of Neurology, Neurosurgery, and Psychiatry 2007;78:190-192
Copyright © 2007 by the BMJ Publishing Group Ltd.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jnnp.2006.091116v1
78/2/190    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ishida, K.
Right arrow Articles by Mizusawa, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ishida, K.
Right arrow Articles by Mizusawa, H.

SHORT REPORT

Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia

Kazuyuki Ishida1, Hiroshi Mitoma2, Yoshiaki Wada3, Teruaki Oka4, Junji Shibahara5, Yuko Saito6, Shigeo Murayama6, Hidehiro Mizusawa7

1 Department of Neurology, Tamagawa Hospital, Setagaya-ku, Tokyo, Japan
2 Mitoma Neurological Clinic, Shinjuku-ku, Tokyo, Japan
3 Department of Rehabilitation, Tamagawa Hospital, Setagaya-ku, Tokyo, Japan
4 Department of Pathology, Kanto Central Hospital, Setagaya-ku, Tokyo, Japan
5 Department of Pathology, University of Tokyo, Bunkyo-ku, Tokyo, Japan
6 Department of Neuropathology, Tokyo Metropolitan Institute of Gerontology, Itabashi-ku, Tokyo, Japan
7 Department of Neurology and Neurological Science, Tokyo Medical and Dental University Graduate School, Bunkyo-ku, Tokyo, Japan

Correspondence to:
Correspondence to:
Dr Kazuyuki Ishida
Institute of Oriental Medicine, Tokyo Women’s Medical University, School of Medicine, 4th floor, Shinjuku NS Building, 2-4-1 Nishi-Shinjuku, Shinjuku-ku, Tokyo 163-0804, Japan; k-ishida{at}iom.twmu.ac.jp


ABSTRACT
Anti-glutamic acid decarboxylase antibody is associated with the development of progressive cerebellar ataxia and slowly progressive insulin-dependent diabetes mellitus. Previously, the neurophysiological characteristics of IgG in the cerebrospinal fluid of a patient with anti-glutamic acid decarboxylase antibody-associated progressive cerebellar ataxia and slowly progressive insulin-dependent diabetes mellitus were reported. Using a voltage-gated whole-cell recording technique, it was observed that the IgG in the cerebrospinal fluid of the patient selectively suppressed the inhibitory postsynaptic currents in the Purkinje cells. The patient died from aspiration pneumonia. Postmortem examination showed almost complete depletion of the Purkinje cells with Bergmann gliosis. Therefore, the main cause of cerebellar ataxia observed in this case may be attributed to the near-complete depletion of the Purkinje cells. In this paper, the pathomechanisms underlying Purkinje cell damage are discussed.


Abbreviations: GAD, glutamic acid decarboxylase; PCA, progressive cerebellar ataxia; SPIDDM, slowly progressive insulin-dependent diabetes mellitus; SPS, stiff-person syndrome




This article has been cited by other articles:


Home page
BrainHome page
A. Saiz, Y. Blanco, L. Sabater, F. Gonzalez, L. Bataller, R. Casamitjana, L. Ramio-Torrenta, and F. Graus
Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association
Brain, August 7, 2008; (2008) awn183v1.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 by the BMJ Publishing Group Ltd.